Benitec Biopharma (BNTC) Non-Current Assets (2019 - 2025)

Benitec Biopharma (BNTC) has 7 years of Non-Current Assets data on file, last reported at $1.1 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets rose 205.92% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at -$100.9 million (down 5240.19% YoY), and the FY2025 full-year result was $1.1 million, up 100.37% from the prior year.
• Non-Current Assets grew to $1.1 million in Q4 2025, from $948000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.5 million in Q3 2021 to a low of -$104.0 million in Q1 2025.
• A 5-year average of -$4.4 million and a median of $877500.0 in 2022 frame the typical range for Non-Current Assets.
• Peak annual rise in Non-Current Assets reached 205.92% in 2025, while the deepest fall reached 16531.28% in 2025.
• Tracing BNTC's Non-Current Assets over 5 years: stood at $1.3 million in 2021, then sank by 30.7% to $930000.0 in 2022, then sank by 40.11% to $557000.0 in 2023, then tumbled by 36.27% to $355000.0 in 2024, then surged by 205.92% to $1.1 million in 2025.
• Business Quant data shows BNTC's Non-Current Assets at $1.1 million in Q4 2025, $948000.0 in Q3 2025, and $1.1 million in Q2 2025.